Celebrating the accomplishments of this incredible innovator! Rosalyn Yalow won the 1977 Nobel Prize in Physiology or Medicine (together with Roger Guillemin and Andrew Schally) for development of the radioimmunoassay technique. #healthcare #medicalimaging lnkd.in/gaJTXC6v

Awesome opportunity lnkd.in/gxbCUAui

lnkd.in/ggjaPjag

Awesome insight from hc1 ‘s Alex Karr on using #data and #healthtech strategically to improve #healthcare lnkd.in/gqHYvgsk

Congratulations William Moss and team 3Aware on a fantastic launch event in Brussels this week! Chris Brown Amelia Hufford Phillip Stoltzfus Kalidip Choudhury lnkd.in/g3CJEiwc

lnkd.in/gnPY4XeR

It’s a big week for 3Aware - lnkd.in/gAvMFpB7 lnkd.in/gphaRWtY

“The skills of the developer will be to figure out, ‘How small do I have to go until I can leverage AI to synthesize that code for me?'” #ai #developer

Introducing our new CEO, Bill Moss! With 20+ years of experience with start-ups like Seven Bridges Genomics, MFX USA, Delphi Technology, NDC Health HVP, TechRx & Revive Technologies, he is taking us to the next level. Welcome Bill! 3aware.ai/2023-06-13

William Moss is a proven leader - Psyched to have you on the team!! lnkd.in/gYqa9ETW

lnkd.in/dg_4B-ri lnkd.in/dJ639Tdp

People are totally freaking out about the #ai era. Should you be? lnkd.in/gXjFifM6

Big announcement- Transformational #aiforhealth to support #medtech cos with #eumdr and other #regulations requiring real world evidence submissions for medical devices William Moss and Chris Brown are building an incredible team! lnkd.in/gVPyqbcx

Awesome #ai #healthtech opportunity lnkd.in/gszvvFtu

Just stmbled upon this gem. I regret to inform you that Digital Human as a Service (DHaaS) is now an acronym

#ai #chatgpt longitudinal data analysis lnkd.in/ggFtuGzg

Six in 10 (61 percent) of respondents said they only access care when they are sick, leaving preventive care by the wayside. lnkd.in/gxMhQY3X

Thankful for our veterans lnkd.in/guY54nVu

#ai creatively solves problems… lnkd.in/gPyxM9rn

“Tech­nolo­gies like these are go­ing to start ad­dress­ing ar­eas of bi­ol­ogy that have been ‘un­drug-gable,’” says Sean Mc­Clain, founder and CEO of Ab­sci Corp., a drug dis­cov­ery com­pany in Van­cou­ver, Wash.  #ai #biopharma Rich Carter lnkd.in/g6x2rKGi